MedPath

Comparison of Pain-Reducing effect between Topical Ethyl Chloride Spray versus Subcutaneous 1% Lidocaine Injection during Two Rods System Contraceptive Implant Insertion: A Randomized Controlled Trial.

Phase 4
Completed
Conditions
Pain
Ethyl Chloride Spray
Lidocaine
Two rods system implant
Anesthetic administration pain
Registration Number
TCTR20201218001
Lead Sponsor
one
Brief Summary

All basic clinical characteristics between the two groups showed no significant difference. Mean VAS during anesthetic in the Ethyl Chloride Spray (ECS) group were significantly lower than in the Lidocaine injection (LI) group (3.92 and 2.89, p 0.01). However, the mean VAS during; (1) implant insertion, (2) 20 min after implant insertion and (3) overall pain, in the ECS group were significantly higher than in the LI group (4.83, 1.61, 3.11 versus 0.98, 0.09, p 0.01)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
110
Inclusion Criteria

1.Thai literate women over 18 Years with parental or caregiver permission who prefer to use two rods system contraceptive implant.
2.No contraindication for one rod system implant.

Exclusion Criteria

1.Known allergic to either analgesic methods.
2.Removal and reinsertion of subdermal implant at the same time.
3.Received pain killer within 4 hours prior to the procedur.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain Score durring Analgesic application Analgesic application 10 cm Visual Analogue Scale for Assessment of Pain Intensity,Pain Score durring Implant insertion Implant insertion 10 cm Visual Analogue Scale for Assessment of Pain Intensity,Pain Score 20 minutes after implant insertion 20 minutes after implant insertion 10 cm Visual Analogue Scale for Assessment of Pain Intensity,Overall Pain Score 20 minutes after implant insertion Pain Score calculated from Pain Score during Analgesic application, Implant insertion and 20 minutes after implant insertion
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath